New anticancer drugs: mitoxantrone and bisantrene
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
New York
Raven Pr.
1983
|
| Schriftenreihe: | European Organization for Research on Treatment of Cancer: Monograph series of the ...
12 |
| Schlagworte: | |
| Beschreibung: | XV, 194 S. |
| ISBN: | 0890048886 |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV000145048 | ||
| 003 | DE-604 | ||
| 007 | t| | ||
| 008 | 870612s1983 xx |||| 00||| eng d | ||
| 020 | |a 0890048886 |9 0-89004-888-6 | ||
| 035 | |a (OCoLC)9555432 | ||
| 035 | |a (DE-599)BVBBV000145048 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-12 |a DE-355 |a DE-188 | ||
| 050 | 0 | |a RC271.M57 | |
| 082 | 0 | |a 616.99/4061 |2 19 | |
| 084 | |a VS 9100 |0 (DE-625)147725:253 |2 rvk | ||
| 245 | 1 | 0 | |a New anticancer drugs |b mitoxantrone and bisantrene |c ed.: Marcel Rozencweig ... |
| 264 | 1 | |a New York |b Raven Pr. |c 1983 | |
| 300 | |a XV, 194 S. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a European Organization for Research on Treatment of Cancer: Monograph series of the ... |v 12 | |
| 650 | 4 | |a Anticancéreux - Congrès | |
| 650 | 4 | |a Cancer - Chimiothérapie - Évaluation - Congrès | |
| 650 | 4 | |a Anthracenes |x therapeutic use |v Congresses | |
| 650 | 4 | |a Anthraquinones |x therapeutic use |v Congresses | |
| 650 | 4 | |a Antineoplastic Agents |x therapeutic use |v Congresses | |
| 650 | 4 | |a Bisantrene hydrochloride |x Testing | |
| 650 | 4 | |a Cancer |x Chemotherapy |x Evaluation | |
| 650 | 4 | |a Drug Evaluation |v Congresses | |
| 650 | 4 | |a Mitoxantrone hydrochloride |x Testing | |
| 650 | 4 | |a Neoplasms |x drug therapy |v Congresses | |
| 650 | 0 | 7 | |a Cytostatikum |0 (DE-588)4068347-3 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Anthracenderivate |0 (DE-588)4142626-5 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Mitoxantron |0 (DE-588)4122287-8 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Bisantren |0 (DE-588)4331873-3 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Onkologie |0 (DE-588)4075658-0 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |2 gnd-content | |
| 689 | 0 | 0 | |a Onkologie |0 (DE-588)4075658-0 |D s |
| 689 | 0 | 1 | |a Mitoxantron |0 (DE-588)4122287-8 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Onkologie |0 (DE-588)4075658-0 |D s |
| 689 | 1 | 1 | |a Bisantren |0 (DE-588)4331873-3 |D s |
| 689 | 1 | |5 DE-604 | |
| 689 | 2 | 0 | |a Mitoxantron |0 (DE-588)4122287-8 |D s |
| 689 | 2 | |5 DE-604 | |
| 689 | 3 | 0 | |a Bisantren |0 (DE-588)4331873-3 |D s |
| 689 | 3 | |5 DE-604 | |
| 689 | 4 | 0 | |a Cytostatikum |0 (DE-588)4068347-3 |D s |
| 689 | 4 | 1 | |a Anthracenderivate |0 (DE-588)4142626-5 |D s |
| 689 | 4 | |5 DE-604 | |
| 700 | 1 | |a Rozencweig, Marcel |e Sonstige |4 oth | |
| 830 | 0 | |a European Organization for Research on Treatment of Cancer: Monograph series of the ... |v 12 |w (DE-604)BV000000650 |9 12 | |
| 943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-000080765 | |
Datensatz im Suchindex
| _version_ | 1823607484568305664 |
|---|---|
| adam_text | |
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV000145048 |
| callnumber-first | R - Medicine |
| callnumber-label | RC271 |
| callnumber-raw | RC271.M57 |
| callnumber-search | RC271.M57 |
| callnumber-sort | RC 3271 M57 |
| callnumber-subject | RC - Internal Medicine |
| classification_rvk | VS 9100 |
| ctrlnum | (OCoLC)9555432 (DE-599)BVBBV000145048 |
| dewey-full | 616.99/4061 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.99/4061 |
| dewey-search | 616.99/4061 |
| dewey-sort | 3616.99 44061 |
| dewey-tens | 610 - Medicine and health |
| discipline | Chemie / Pharmazie Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nam a2200000 cb4500</leader><controlfield tag="001">BV000145048</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="007">t|</controlfield><controlfield tag="008">870612s1983 xx |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0890048886</subfield><subfield code="9">0-89004-888-6</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)9555432</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV000145048</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-355</subfield><subfield code="a">DE-188</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC271.M57</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.99/4061</subfield><subfield code="2">19</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">VS 9100</subfield><subfield code="0">(DE-625)147725:253</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">New anticancer drugs</subfield><subfield code="b">mitoxantrone and bisantrene</subfield><subfield code="c">ed.: Marcel Rozencweig ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York</subfield><subfield code="b">Raven Pr.</subfield><subfield code="c">1983</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XV, 194 S.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">European Organization for Research on Treatment of Cancer: Monograph series of the ...</subfield><subfield code="v">12</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Anticancéreux - Congrès</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer - Chimiothérapie - Évaluation - Congrès</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Anthracenes</subfield><subfield code="x">therapeutic use</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Anthraquinones</subfield><subfield code="x">therapeutic use</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antineoplastic Agents</subfield><subfield code="x">therapeutic use</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Bisantrene hydrochloride</subfield><subfield code="x">Testing</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer</subfield><subfield code="x">Chemotherapy</subfield><subfield code="x">Evaluation</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Evaluation</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Mitoxantrone hydrochloride</subfield><subfield code="x">Testing</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neoplasms</subfield><subfield code="x">drug therapy</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Cytostatikum</subfield><subfield code="0">(DE-588)4068347-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Anthracenderivate</subfield><subfield code="0">(DE-588)4142626-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Mitoxantron</subfield><subfield code="0">(DE-588)4122287-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Bisantren</subfield><subfield code="0">(DE-588)4331873-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Onkologie</subfield><subfield code="0">(DE-588)4075658-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Onkologie</subfield><subfield code="0">(DE-588)4075658-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Mitoxantron</subfield><subfield code="0">(DE-588)4122287-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Onkologie</subfield><subfield code="0">(DE-588)4075658-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Bisantren</subfield><subfield code="0">(DE-588)4331873-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">Mitoxantron</subfield><subfield code="0">(DE-588)4122287-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="3" ind2="0"><subfield code="a">Bisantren</subfield><subfield code="0">(DE-588)4331873-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="4" ind2="0"><subfield code="a">Cytostatikum</subfield><subfield code="0">(DE-588)4068347-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="4" ind2="1"><subfield code="a">Anthracenderivate</subfield><subfield code="0">(DE-588)4142626-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="4" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rozencweig, Marcel</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">European Organization for Research on Treatment of Cancer: Monograph series of the ...</subfield><subfield code="v">12</subfield><subfield code="w">(DE-604)BV000000650</subfield><subfield code="9">12</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-000080765</subfield></datafield></record></collection> |
| genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content (DE-588)1071861417 Konferenzschrift gnd-content |
| genre_facet | Aufsatzsammlung Konferenzschrift |
| id | DE-604.BV000145048 |
| illustrated | Not Illustrated |
| indexdate | 2025-02-09T19:00:21Z |
| institution | BVB |
| isbn | 0890048886 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-000080765 |
| oclc_num | 9555432 |
| open_access_boolean | |
| owner | DE-12 DE-355 DE-BY-UBR DE-188 |
| owner_facet | DE-12 DE-355 DE-BY-UBR DE-188 |
| physical | XV, 194 S. |
| publishDate | 1983 |
| publishDateSearch | 1983 |
| publishDateSort | 1983 |
| publisher | Raven Pr. |
| record_format | marc |
| series | European Organization for Research on Treatment of Cancer: Monograph series of the ... |
| series2 | European Organization for Research on Treatment of Cancer: Monograph series of the ... |
| spelling | New anticancer drugs mitoxantrone and bisantrene ed.: Marcel Rozencweig ... New York Raven Pr. 1983 XV, 194 S. txt rdacontent n rdamedia nc rdacarrier European Organization for Research on Treatment of Cancer: Monograph series of the ... 12 Anticancéreux - Congrès Cancer - Chimiothérapie - Évaluation - Congrès Anthracenes therapeutic use Congresses Anthraquinones therapeutic use Congresses Antineoplastic Agents therapeutic use Congresses Bisantrene hydrochloride Testing Cancer Chemotherapy Evaluation Drug Evaluation Congresses Mitoxantrone hydrochloride Testing Neoplasms drug therapy Congresses Cytostatikum (DE-588)4068347-3 gnd rswk-swf Anthracenderivate (DE-588)4142626-5 gnd rswk-swf Mitoxantron (DE-588)4122287-8 gnd rswk-swf Bisantren (DE-588)4331873-3 gnd rswk-swf Onkologie (DE-588)4075658-0 gnd rswk-swf (DE-588)4143413-4 Aufsatzsammlung gnd-content (DE-588)1071861417 Konferenzschrift gnd-content Onkologie (DE-588)4075658-0 s Mitoxantron (DE-588)4122287-8 s DE-604 Bisantren (DE-588)4331873-3 s Cytostatikum (DE-588)4068347-3 s Anthracenderivate (DE-588)4142626-5 s Rozencweig, Marcel Sonstige oth European Organization for Research on Treatment of Cancer: Monograph series of the ... 12 (DE-604)BV000000650 12 |
| spellingShingle | New anticancer drugs mitoxantrone and bisantrene European Organization for Research on Treatment of Cancer: Monograph series of the ... Anticancéreux - Congrès Cancer - Chimiothérapie - Évaluation - Congrès Anthracenes therapeutic use Congresses Anthraquinones therapeutic use Congresses Antineoplastic Agents therapeutic use Congresses Bisantrene hydrochloride Testing Cancer Chemotherapy Evaluation Drug Evaluation Congresses Mitoxantrone hydrochloride Testing Neoplasms drug therapy Congresses Cytostatikum (DE-588)4068347-3 gnd Anthracenderivate (DE-588)4142626-5 gnd Mitoxantron (DE-588)4122287-8 gnd Bisantren (DE-588)4331873-3 gnd Onkologie (DE-588)4075658-0 gnd |
| subject_GND | (DE-588)4068347-3 (DE-588)4142626-5 (DE-588)4122287-8 (DE-588)4331873-3 (DE-588)4075658-0 (DE-588)4143413-4 (DE-588)1071861417 |
| title | New anticancer drugs mitoxantrone and bisantrene |
| title_auth | New anticancer drugs mitoxantrone and bisantrene |
| title_exact_search | New anticancer drugs mitoxantrone and bisantrene |
| title_full | New anticancer drugs mitoxantrone and bisantrene ed.: Marcel Rozencweig ... |
| title_fullStr | New anticancer drugs mitoxantrone and bisantrene ed.: Marcel Rozencweig ... |
| title_full_unstemmed | New anticancer drugs mitoxantrone and bisantrene ed.: Marcel Rozencweig ... |
| title_short | New anticancer drugs |
| title_sort | new anticancer drugs mitoxantrone and bisantrene |
| title_sub | mitoxantrone and bisantrene |
| topic | Anticancéreux - Congrès Cancer - Chimiothérapie - Évaluation - Congrès Anthracenes therapeutic use Congresses Anthraquinones therapeutic use Congresses Antineoplastic Agents therapeutic use Congresses Bisantrene hydrochloride Testing Cancer Chemotherapy Evaluation Drug Evaluation Congresses Mitoxantrone hydrochloride Testing Neoplasms drug therapy Congresses Cytostatikum (DE-588)4068347-3 gnd Anthracenderivate (DE-588)4142626-5 gnd Mitoxantron (DE-588)4122287-8 gnd Bisantren (DE-588)4331873-3 gnd Onkologie (DE-588)4075658-0 gnd |
| topic_facet | Anticancéreux - Congrès Cancer - Chimiothérapie - Évaluation - Congrès Anthracenes therapeutic use Congresses Anthraquinones therapeutic use Congresses Antineoplastic Agents therapeutic use Congresses Bisantrene hydrochloride Testing Cancer Chemotherapy Evaluation Drug Evaluation Congresses Mitoxantrone hydrochloride Testing Neoplasms drug therapy Congresses Cytostatikum Anthracenderivate Mitoxantron Bisantren Onkologie Aufsatzsammlung Konferenzschrift |
| volume_link | (DE-604)BV000000650 |
| work_keys_str_mv | AT rozencweigmarcel newanticancerdrugsmitoxantroneandbisantrene |